8-KLeadership ChangesExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Dec 12, 2022)

Filed December 12, 2022For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) announced a key addition to its Board of Directors with the appointment of Kristen L. Gil as an independent director, effective December 9, 2022. Ms. Gil's appointment includes her role on the Audit and Finance Committee, a critical committee overseeing financial reporting and internal controls. This move is investor-focused as it strengthens the board's oversight capabilities, particularly in financial matters. Ms. Gil will be compensated according to the company's standard director compensation program and will receive indemnification in line with UNH's customary practices. The filing also clarifies that there are no undisclosed arrangements or conflicts of interest concerning her appointment, assuring investors of good governance practices. The press release detailing this appointment is attached as an exhibit.

Key Highlights

  • 1Appointment of Kristen L. Gil as an independent director to the Board of Directors, effective December 9, 2022.
  • 2Ms. Gil has been appointed to the Audit and Finance Committee, enhancing financial oversight.
  • 3Her compensation will follow the company's standard program for non-employee directors.
  • 4UNH is entering into its standard indemnification agreement with Ms. Gil.
  • 5The appointment is not based on any undisclosed arrangements or understandings.
  • 6Ms. Gil has no material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.
  • 7The press release announcing the appointment is filed as Exhibit 99.1.

Frequently Asked Questions

Kristen L. Gil has been appointed as an independent director to the UnitedHealth Group Inc. Board of Directors. Her appointment strengthens the board's expertise and oversight capabilities, particularly within the Audit and Finance Committee.

Her role on the Audit and Finance Committee is significant as this committee is responsible for overseeing the company's financial reporting processes, internal controls, and independent auditors. This appointment suggests a focus on maintaining strong financial governance.

Ms. Gil will receive compensation in accordance with UnitedHealth Group's standard compensation program for its non-employee directors. The details of this program are further described in the company's 2022 proxy statement.

According to the filing, there are no undisclosed arrangements or understandings concerning Ms. Gil's appointment, and she has no direct or indirect material interest in any transaction that requires disclosure under the relevant SEC regulations, indicating a clean appointment.